Assessment |
Biopsychology |
Comparative |
Cognitive |
Developmental |
Language |
Individual differences |
Personality |
Philosophy |
Social |
Methods |
Statistics |
Clinical |
Educational |
Industrial |
Professional items |
World psychology |
Biological: Behavioural genetics · Evolutionary psychology · Neuroanatomy · Neurochemistry · Neuroendocrinology · Neuroscience · Psychoneuroimmunology · Physiological Psychology · Psychopharmacology (Index, Outline)
|
Methoxamine chemical structure | |
IUPAC name | |
| CAS number 390-28-3 |
ATC code C01CA10 |
| PubChem 6082 |
DrugBank [1] |
| Chemical formula | |
| Molecular weight | 211.258 |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Pregnancy category | |
| Legal status | |
| Routes of administration | |
Methoxamine is an α1-adrenergic receptor agonist, similar to phenylephrine. It induces vasoconstriction of skin and splanchnic blood vessels, thereby increasing peripheral vascular resistance and raising mean arterial blood pressure. Because of its hypertensive effects, it may evoke a compensatory reflex bradycardia via the baroreceptors.
Uses[]
The clinical use of methoxamine is for Paroxysmal supraventricular tachycardia.
See also[]
Template:Adrenergic agonists Template:Cardiac stimulants excluding cardiac glycosides